Archives

by in
Entry Author Date Location
From Yeast, Yumanity Looks to Give Rise to Critical Neuro Drugs 01/26/15 Boston
As Box IPOs, a Competitor Previews the Market Share Battle 01/23/15 San Francisco
East Coast Biotech Roundup: Alnylam, Stock Offerings, Curis, & More 01/23/15 Boston
In the Jiu-Jitsu Match of Biotech Risk, a Reminder of Other Paths 01/20/15 National
J.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex 01/16/15 National
Box Steps Back Onto IPO Runway 01/09/15 San Francisco
East Coast Biotech Roundup: Pre-J.P. Morgan Preening Edition 01/09/15 Boston
One Week Into The New Year, Five Biotechs Reel in $220M Venture Cash 01/08/15 National
Startup 101: Texas Venture Labs Pairs UT Students With Entrepreneurs 01/07/15 Texas
Don’t Get Comfortable: 5 Biopharma Flashpoints to Consider in 2015 01/06/15 National
With Massive Venture Round, Moderna Has $450M Reasons to Stay Private 01/05/15 Boston
Larry Corey, Cofounder of 2014 Top Biotech Juno: “It’s No Outlier” 01/05/15 Seattle
Texas’s Innovative 2014: IPOs, Startup Funding Programs & SXSW 12/31/14 Texas
West Coast Biotech Roundup: Gilead/AbbVie, Juno, Auspex, Bina & More 12/23/14 San Francisco
Officials Say Fuji’s Purchase of Kalon Boosts Texas’s Biotech Profile 12/22/14 Texas
Juno Just Raised A Ton of Cash. Here Comes the Spending Part. 12/19/14 Seattle
With $2B Market Cap and New Shareholder Rules, Juno Ready for Debut 12/18/14 Seattle
Houston’s Bellicum Pharma Rides T-Cell Therapy Wave to $140M IPO 12/18/14 Texas
Connecture Prices Well Below Projection in Nasdaq Debut 12/12/14 Wisconsin
Lending Club Shares Soar 56 Percent In Market Debut 12/11/14 San Francisco
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More 12/05/14 Boston
West Coast Biotech Roundup: Amgen, Ariosa, Avanir, Audentes & More 12/04/14 San Diego
TX Roundup: Need, Experiment Engine, Bigcommerce, Bellicum, CS Disco 12/02/14 Texas
West Coast Biotech Roundup: Gilead, Juno, Hutch, Fibrogen & More 11/20/14 Seattle
Houston Biotech Firm Bellicum Pharmaceuticals Files for IPO 11/19/14 Texas
Déjà Vu for Agios as Second Drug Shines in Small Blood Cancer Study 11/18/14 Boston
Juno, Less Than a Year Old, Lines up IPO to Fund Cancer Work 11/17/14 Seattle
As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO 11/14/14 San Francisco
Sage’s Drug For Rare Epilepsy Shows Promise in Small Study 11/10/14 Boston
Page 1 of 14 next page »